353 followers
RT @FrontImmunol: New Research: Case Report: Cadonilimab-related toxic epidermal necrolysis-like reactions successfully treated with supple…
RT @FrontImmunol: New Research: Case Report: Cadonilimab-related toxic epidermal necrolysis-like reactions successfully treated with supple…
New Research: Case Report: Cadonilimab-related toxic epidermal necrolysis-like reactions successfully treated with supplemental Adalimumab: Cadonilimab is the first bi-specific antibody approved for certain malignancies in June 2022, which… #immunology htt